title: TGF-beta/SMAD signaling and its involvement in tumor progression.
abstract: Cytokines of the transforming growth factor-beta (TGF-beta) superfamily are multifunctional peptides that regulate growth and differentiation of various types of cells. Members of the TGF-beta superfamily bind to type 11 and type I serine/threonine kinase receptors, which mediate intracellular signals through SMAD proteins. Of 3 subtypes of SMADs, receptor-regulated SMADs are phosphorylated by the serine/threonine kinase receptors, form complexes with common-mediator SMAD, and move into the nucleus, where they act as components of transcription factor complexes. Abnormalities of the TGF-beta receptors and SMADs have been detected in various tumors, including colorectal cancers and pancreatic cancers. Inhibitory SMADs and transcriptional co-repressors, including c-Ski and SnoN, repress the TGF-beta/SMAD signaling. Perturbation of the TGF-beta/SMAD signaling pathway may result in progression of tumors through resistance of the cells to the growth inhibition induced by TGF-beta.
authors.affiliation: Department of Biochemistry, The Center Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan. miyazono-ind@umin.ac.jp
authors.forename: K
authors.initials: K
authors.lastname: Miyazono
mesh_terms: D000818:Animals; D018450:Disease Progression; D006801:Humans; D009369:Neoplasms / Q000473:pathology*; D015398:Signal Transduction / Q000502:physiology*; D014157:Transcription Factors / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000502:physiology*
chemical_list: D014157:Transcription Factors; D016212:Transforming Growth Factor beta